Literature DB >> 4681803

Distribution and metabolism of disodium cromoglycate in rats.

G F Moss, K M Jones, J T Ritchie, J S Cox.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4681803     DOI: 10.1016/0041-008x(70)90043-8

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  11 in total

1.  Oral delivery of sodium cromolyn: preliminary studies in vivo and in vitro.

Authors:  A Leone-Bay; H Leipold; D Sarubbi; B Variano; T Rivera; R A Baughman
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

2.  The pharmacokinetics of sodium cromoglycate in man after intravenous and inhalation administration.

Authors:  M G Neale; K Brown; R W Hodder; R M Auty
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

3.  Inhibition of immediate hypersensitivity reactions by disodium cromoglycate.

Authors:  D S Thomson; D P Evans
Journal:  Clin Exp Immunol       Date:  1973-04       Impact factor: 4.330

4.  Effect of inducers on the metabolism and excretion of disodium cromoglycate in rats.

Authors:  M G Neale; G F Moss
Journal:  Biochem J       Date:  1972-11       Impact factor: 3.857

Review 5.  Disodium cromoglycate in allergic respiratory disease.

Authors: 
Journal:  Br Med J       Date:  1972-04-15

6.  The absorption, excretion and metabolism of disodium (14C)cromoglycate in man.

Authors:  S R Walker; A J Richards; J W Paterson
Journal:  Biochem J       Date:  1971-11       Impact factor: 3.857

7.  The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man.

Authors:  K M Taylor; G Taylor; I W Kellaway; J Stevens
Journal:  Pharm Res       Date:  1989-07       Impact factor: 4.200

8.  Disposition of disodium cromoglycate administered in three particle sizes.

Authors:  S H Curry; A J Taylor; S Evans; S Godfrey; E Zeidifard
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

9.  Inhibition of immediate hypersensitivity reactions in the rat by disodium cromoglycate and nitroindanedione.

Authors:  B A Spicer; J W Ross; H Smith
Journal:  Clin Exp Immunol       Date:  1975-09       Impact factor: 4.330

Review 10.  Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1974       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.